Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes
Identification of the immunomodulatory and regenerative properties of mesenchymal stem cells (MSCs) have made them an attractive alternative therapeutic option for diseases with no effective treatment options. Numerous clinical trials have followed; however, issues such as infusional toxicity and ce...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical medicine 2021-02, Vol.10 (4), p.711 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | 711 |
| container_title | Journal of clinical medicine |
| container_volume | 10 |
| creator | Lee, Byung-Chul Kang, Insung Yu, Kyung-Rok |
| description | Identification of the immunomodulatory and regenerative properties of mesenchymal stem cells (MSCs) have made them an attractive alternative therapeutic option for diseases with no effective treatment options. Numerous clinical trials have followed; however, issues such as infusional toxicity and cellular rejection have been reported. To address these problems associated with cell-based therapy, MSC exosome therapy was developed and has shown promising clinical outcomes. MSC exosomes are nanosized vesicles secreted from MSCs and represent a non-cellular therapeutic agent. MSC exosomes retain therapeutic features of the cells from which they originated including genetic material, lipids, and proteins. Similar to MSCs, exosomes can induce cell differentiation, immunoregulation, angiogenesis, and tumor suppression. MSC exosomes have therefore been employed in several experimental models and clinical studies. Here, we review the therapeutic potential of MSC-derived exosomes and summarize currently ongoing clinical trials according to disease type. In addition, we propose several functional enhancement strategies for the effective clinical application of MSC exosome therapy. |
| doi_str_mv | 10.3390/jcm10040711 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7916919</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2498493900</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-e89e11fef352ce5ed70f3252157161352f8f83170eb86b59bd59f602ebf2e4943</originalsourceid><addsrcrecordid>eNpdkUtP3TAQhS3UChCw6h5Z6oYKhfqVON5UQuEpgbrgsnYdZ9zrqyS-2Akq_x4jHrrUG1vjb47OzEHoGyUnnCvyc2UHSoggktIttMuIlAXhNf-y8d5BBymtSD51LRiV22iH80oSRtgu-rNYQjRrmCdv8QWYaY6QsBk7fL_uzAQdbno_emt6vIje9AkHh28hwWiXT0Ou3k0w4Ab6Hh_d3jU_ijOI_jG3nf8LKQyQ9tFXl9vg4O3eQ_cX54vmqrj5fXndnN4UVhA1FVAroNSB4yWzUEInieOsZLSUtKK56GpXcyoJtHXVlqrtSuUqwqB1DIQSfA_9etVdz-0AnYVxiqbX6-gHE590MF5__hn9Uv8Nj1oqWimqssDRm0AMDzOkSQ8-2TyYGSHMSTOhaqHyzklGv_-HrsIcxzyeZpWgRAjGXhwdv1I2hpQiuA8zlOiX8PRGeJk-3PT_wb5HxZ8Bc7ST1w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2641044224</pqid></control><display><type>article</type><title>Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Lee, Byung-Chul ; Kang, Insung ; Yu, Kyung-Rok</creator><creatorcontrib>Lee, Byung-Chul ; Kang, Insung ; Yu, Kyung-Rok</creatorcontrib><description>Identification of the immunomodulatory and regenerative properties of mesenchymal stem cells (MSCs) have made them an attractive alternative therapeutic option for diseases with no effective treatment options. Numerous clinical trials have followed; however, issues such as infusional toxicity and cellular rejection have been reported. To address these problems associated with cell-based therapy, MSC exosome therapy was developed and has shown promising clinical outcomes. MSC exosomes are nanosized vesicles secreted from MSCs and represent a non-cellular therapeutic agent. MSC exosomes retain therapeutic features of the cells from which they originated including genetic material, lipids, and proteins. Similar to MSCs, exosomes can induce cell differentiation, immunoregulation, angiogenesis, and tumor suppression. MSC exosomes have therefore been employed in several experimental models and clinical studies. Here, we review the therapeutic potential of MSC-derived exosomes and summarize currently ongoing clinical trials according to disease type. In addition, we propose several functional enhancement strategies for the effective clinical application of MSC exosome therapy.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm10040711</identifier><identifier>PMID: 33670202</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Apoptosis ; Clinical medicine ; Clinical trials ; Graft versus host disease ; Homeostasis ; Immune system ; Medical prognosis ; Review ; Stem cells ; Tissue engineering</subject><ispartof>Journal of clinical medicine, 2021-02, Vol.10 (4), p.711</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-e89e11fef352ce5ed70f3252157161352f8f83170eb86b59bd59f602ebf2e4943</citedby><cites>FETCH-LOGICAL-c409t-e89e11fef352ce5ed70f3252157161352f8f83170eb86b59bd59f602ebf2e4943</cites><orcidid>0000-0002-4685-3223</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916919/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916919/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33670202$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Byung-Chul</creatorcontrib><creatorcontrib>Kang, Insung</creatorcontrib><creatorcontrib>Yu, Kyung-Rok</creatorcontrib><title>Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>Identification of the immunomodulatory and regenerative properties of mesenchymal stem cells (MSCs) have made them an attractive alternative therapeutic option for diseases with no effective treatment options. Numerous clinical trials have followed; however, issues such as infusional toxicity and cellular rejection have been reported. To address these problems associated with cell-based therapy, MSC exosome therapy was developed and has shown promising clinical outcomes. MSC exosomes are nanosized vesicles secreted from MSCs and represent a non-cellular therapeutic agent. MSC exosomes retain therapeutic features of the cells from which they originated including genetic material, lipids, and proteins. Similar to MSCs, exosomes can induce cell differentiation, immunoregulation, angiogenesis, and tumor suppression. MSC exosomes have therefore been employed in several experimental models and clinical studies. Here, we review the therapeutic potential of MSC-derived exosomes and summarize currently ongoing clinical trials according to disease type. In addition, we propose several functional enhancement strategies for the effective clinical application of MSC exosome therapy.</description><subject>Apoptosis</subject><subject>Clinical medicine</subject><subject>Clinical trials</subject><subject>Graft versus host disease</subject><subject>Homeostasis</subject><subject>Immune system</subject><subject>Medical prognosis</subject><subject>Review</subject><subject>Stem cells</subject><subject>Tissue engineering</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkUtP3TAQhS3UChCw6h5Z6oYKhfqVON5UQuEpgbrgsnYdZ9zrqyS-2Akq_x4jHrrUG1vjb47OzEHoGyUnnCvyc2UHSoggktIttMuIlAXhNf-y8d5BBymtSD51LRiV22iH80oSRtgu-rNYQjRrmCdv8QWYaY6QsBk7fL_uzAQdbno_emt6vIje9AkHh28hwWiXT0Ou3k0w4Ab6Hh_d3jU_ijOI_jG3nf8LKQyQ9tFXl9vg4O3eQ_cX54vmqrj5fXndnN4UVhA1FVAroNSB4yWzUEInieOsZLSUtKK56GpXcyoJtHXVlqrtSuUqwqB1DIQSfA_9etVdz-0AnYVxiqbX6-gHE590MF5__hn9Uv8Nj1oqWimqssDRm0AMDzOkSQ8-2TyYGSHMSTOhaqHyzklGv_-HrsIcxzyeZpWgRAjGXhwdv1I2hpQiuA8zlOiX8PRGeJk-3PT_wb5HxZ8Bc7ST1w</recordid><startdate>20210211</startdate><enddate>20210211</enddate><creator>Lee, Byung-Chul</creator><creator>Kang, Insung</creator><creator>Yu, Kyung-Rok</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4685-3223</orcidid></search><sort><creationdate>20210211</creationdate><title>Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes</title><author>Lee, Byung-Chul ; Kang, Insung ; Yu, Kyung-Rok</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-e89e11fef352ce5ed70f3252157161352f8f83170eb86b59bd59f602ebf2e4943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Apoptosis</topic><topic>Clinical medicine</topic><topic>Clinical trials</topic><topic>Graft versus host disease</topic><topic>Homeostasis</topic><topic>Immune system</topic><topic>Medical prognosis</topic><topic>Review</topic><topic>Stem cells</topic><topic>Tissue engineering</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Byung-Chul</creatorcontrib><creatorcontrib>Kang, Insung</creatorcontrib><creatorcontrib>Yu, Kyung-Rok</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Byung-Chul</au><au>Kang, Insung</au><au>Yu, Kyung-Rok</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2021-02-11</date><risdate>2021</risdate><volume>10</volume><issue>4</issue><spage>711</spage><pages>711-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>Identification of the immunomodulatory and regenerative properties of mesenchymal stem cells (MSCs) have made them an attractive alternative therapeutic option for diseases with no effective treatment options. Numerous clinical trials have followed; however, issues such as infusional toxicity and cellular rejection have been reported. To address these problems associated with cell-based therapy, MSC exosome therapy was developed and has shown promising clinical outcomes. MSC exosomes are nanosized vesicles secreted from MSCs and represent a non-cellular therapeutic agent. MSC exosomes retain therapeutic features of the cells from which they originated including genetic material, lipids, and proteins. Similar to MSCs, exosomes can induce cell differentiation, immunoregulation, angiogenesis, and tumor suppression. MSC exosomes have therefore been employed in several experimental models and clinical studies. Here, we review the therapeutic potential of MSC-derived exosomes and summarize currently ongoing clinical trials according to disease type. In addition, we propose several functional enhancement strategies for the effective clinical application of MSC exosome therapy.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33670202</pmid><doi>10.3390/jcm10040711</doi><orcidid>https://orcid.org/0000-0002-4685-3223</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2077-0383 |
| ispartof | Journal of clinical medicine, 2021-02, Vol.10 (4), p.711 |
| issn | 2077-0383 2077-0383 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7916919 |
| source | PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Apoptosis Clinical medicine Clinical trials Graft versus host disease Homeostasis Immune system Medical prognosis Review Stem cells Tissue engineering |
| title | Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T00%3A15%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20Features%20and%20Updated%20Clinical%20Trials%20of%20Mesenchymal%20Stem%20Cell%20(MSC)-Derived%20Exosomes&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Lee,%20Byung-Chul&rft.date=2021-02-11&rft.volume=10&rft.issue=4&rft.spage=711&rft.pages=711-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm10040711&rft_dat=%3Cproquest_pubme%3E2498493900%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2641044224&rft_id=info:pmid/33670202&rfr_iscdi=true |